Pharmaceuticals The future of launch excellence is generative AI Last updated: August 15, 2024 6:01 pm By bexib 0 Min Read Share SHARE How can pharmaceutical companies gain value from using generative AI in their go-to-market strategies and decision-making, including mitigating launch challenges and enhancing customer conversations? You Might Also Like APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins New ways to determine drug value with health equity in mind Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer Share This Article Facebook Twitter Email Print Previous Article Mortgage delinquencies rise in Q2 2024 Next Article Russia remains silent on link between ruble’s fall and Ukraine attacks Reuters – Investorempires.com Leave a comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Stay ConnectedFacebookLikeTwitterFollowYoutubeSubscribeTelegramFollowLatest News Selfridges ringing in the new year on the roof of San Carlo’s Alto Hospitality & Tourism Season 2024: Exceeding expectations at Borghese Contemporary Hotel Hospitality & Tourism JPMorgan and Bank of America respond to CFPB lawsuit Banking Zell says CFPB lawsuit against big banks is ‘regulatory overreach’ Banking